Pilot study of antiretroviral therapy in Djibouti

A cross-sectional survey was conducted among 112 HIV positive patients who had received antiretroviral therapy for >3 months to assess the efficacy of treatment (viral load 70%.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Eastern Mediterranean health journal 2007-11, Vol.13 (6), p.1274-1285
Hauptverfasser:	Ahmed, A A, Latoundji, S
Format:	Artikel
Sprache:	eng ; fre
Schlagworte:	Acquired Immunodeficiency Syndrome - blood Acquired Immunodeficiency Syndrome - drug therapy Acquired Immunodeficiency Syndrome - immunology Acquired Immunodeficiency Syndrome - virology Adult Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Antiretroviral Therapy, Highly Active - adverse effects Antiretroviral Therapy, Highly Active - methods Benzoxazines - therapeutic use Body Mass Index CD4 Lymphocyte Count Cross-Sectional Studies Dideoxynucleosides - therapeutic use Djibouti Female Humans Karnofsky Performance Status Lamivudine - therapeutic use Male Nevirapine - therapeutic use Occupations - statistics & numerical data Pilot Projects Severity of Illness Index Statistics, Nonparametric Treatment Outcome Viral Load Zidovudine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A cross-sectional survey was conducted among 112 HIV positive patients who had received antiretroviral therapy for >3 months to assess the efficacy of treatment (viral load 70%.
ISSN:	1020-3397 1687-1634
DOI:	10.26719/2007.13.6.1274